title: [Limbal stem cell deficiency management. A review].
abstract: Limbal stem cell deficiency is predominantly caused by severe eye burns resulting in a decreased or a complete ablation of the regenerative potential of these stem cells. The inability to reconstruct the corneal epithelium further leads conjunctivalization of the gimbal-epithelial barrier. These abnormalities collectively result in the progressive opacification of the cornea responsible for blindness that is driven by chronic corneal ulceration and neovascularization. The underlying pathology of the cornea affects the homeostasis of the neighboring conjunctiva, eyelids, and tear film. Therefore, the ocular reconstruction to treat limbal stem cell deficiency is quite prolonged and involves a continued treatment plan. The management of limbal stem cell deficiency has undergone a multitude of changes over the past several decades. The understanding of limbal anatomy and physiology, as well as therapeutic advances in the stem cell field have propelled the development of new treatments offering new hope to severely disabled patients. Cultivated limbal epithelial and oral mucosal epithelial transplantations are therefore viable alternatives that could be utilized for the treatment of limbal stem cell deficiency.
authors.affiliation: Cornea Center of Excellence, Harvard Medical School, Schepens Eye Research Institute, 20, Staniford Street, Boston, 02114-MA, États-Unis; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, 243, Charles Street, Boston, 02114-MA, États-Unis; Banque de cornée de Lyon, pavillon I, hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France; Service d'ophtalmologie, pavillon C, hôpital Edouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France; Université Claude-Bernard Lyon-I, 43, boulevard du 11-Novembre-1918, 69100 Villeurbanne, France. Electronic address: viridiana_kocaba@meei.harvard.edu.
authors.forename: V
authors.initials: V
authors.lastname: Kocaba
authors.affiliation: Banque de cornée de Lyon, pavillon I, hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France.
authors.forename: O
authors.initials: O
authors.lastname: Damour
authors.affiliation: Banque de cornée de Lyon, pavillon I, hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Auxenfans
authors.affiliation: Banque de cornée de Lyon, pavillon I, hôpital Edouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Lyon, France; Service d'ophtalmologie, pavillon C, hôpital Edouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France; Université Claude-Bernard Lyon-I, 43, boulevard du 11-Novembre-1918, 69100 Villeurbanne, France.
authors.forename: C
authors.initials: C
authors.lastname: Burillon
mesh_terms: D017690:Cell Transplantation / Q000379:methods; D003316:Corneal Diseases / Q000473:pathology / Q000628:therapy*; D019573:Epithelium, Corneal / Q000473:pathology / Q000502:physiology; D006801:Humans; D016850:Limbus Corneae / Q000473:pathology*; D019651:Plastic Surgery Procedures; D012038:Regeneration / Q000502:physiology; D013234:Stem Cells / Q000473:pathology*
keywords: Cellular therapy; Cornea; Cornée; Déficit en cellules souches limbiques; Limbal reconstruction; Limbal stem cell deficiency; Limbe; Limbus; Reconstruction limbique; Thérapie cellulaire